Green tea supplement backed for prostate cancer reduction: RCT findings

By Nathan Gray contact

- Last updated on GMT

Green tea supplement backed for prostate cancer reduction: RCT findings

Related tags: Prostate cancer

Consumption of a green tea extract has been suggested to reduce rates of cancer in certain indiviuals while reducing levels of the cancer biomarker prostate-specific antigen (PSA), say researchers.

Findings from the randomised, placebo controlled trial, suggest that daily consumption of a standardised, decaffeinated catechin mixture containing 400 mg epigallocatechin-3-gallate (EGCG) per day for one yearreduced combined rates of prostate cancer and atypical small acinar proliferation rates, as well as decreased levels of prostate-specific antigen in men who have premalignant prostate lesions or high-grade intraepithelial neoplasia.

The goal of the trial was to evaluate if a one-year intervention with green tea catechins (Polyphenon E ) could suppress prostate cancer development in men who had high-grade intraepithelial neoplasia (HGPIN) or atypical small acinar proliferation (ASAP).

Writing in Cancer Prevention Research, ​the research team reported findings from the trial – revealing that overall the difference in the number of prostate cancer cases at the end of one year between the two treatment groups was not statistically significant.

However, in men who only had HGPIN at the beginning of the trial, they observed a lower combined rate of ASAP and prostate cancer development with Polyophenon E (Poly E), said the team – led by Dr Nagi Kumar from Moffitt Cancer Center.

“This finding was driven by a decrease in ASAP diagnoses on the Poly E (0/26) compared to the placebo arm (5/25),”​ explained Kumar and colleagues, who added that a decrease in serum prostate specific antigen (PSA) was observed in people supplemented with the green tea product.

Study details

The researcher team compared Polyphenon E in 49 men to placebo tablets in 48 men over a one year treatment period, after pre-clinical, epidemiological and prior clinical trial data suggested that green tea catechins (GTCs) could reduce prostate cancer risk.

The 97 men all had high-grade prostatic intraepithelial neoplasia (HGPIN) and/or atypical small acinar proliferation (ASAP), and the primary study endpoint was a comparison of the cumulative one-year prostate cancer rates on the two study arms. Secondary measures included the cumulative rate of prostate cancer, blood PSA levels, and the rate of development of ASAP in men without ASAP but with HGPIN at baseline.

According to Kumar and colleagues, no significant differences were found in the number of total prostate cases were observed, with 5 cases in 49 participants for PolyE and 9 cases in 48 for placebo.

“A secondary endpoint comparing the cumulative rate of prostate cancer plus ASAP among men with HGPIN without ASAP at baseline, revealed a decrease in this composite endpoint: 3/26 (PolyE) versus 10/25 (placebo),”​ said the team.

Additionally, men receiving the green tea supplement had a significant decrease in prostate-specific antigen (PSA) levels – a biomarker that in combination with other risk factors is used to screen patients for prostate cancer, and high levels signify a higher risk of prostate cancer.

Source: Cancer Prevention Research
Published online ahead of print, doi:  10.1158/1940-6207.CAPR-14-0324
“Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention”
Authors: Nagi B. Kumar, et al

Related news

Show more

Related products

show more

Indena’s approach in supporting sport nutrition

Indena’s approach in supporting sport nutrition

Indena: the botanical ingredient of Health Food industry | 22-Nov-2018 | Technical / White Paper

Edible plants confirm to be a paramount source of precious substances able to help in maintaining the overall wellbeing and complement the nutrition of...

Launching a unique cocoa extract processed sustainably

Launching a unique cocoa extract processed sustainably

Robertet Health & Beauty | 21-Nov-2018 | Technical / White Paper

A sweet treat and the ultimate symbol of delicacy, a mystical medicinal ingredient, an invigorating bitter beverage or even the food of the gods, cocoa...

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

Gee Lawson Nutritional - LEHVOSS Group | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Related suppliers

1 comment

Men slow to act

Posted by Gavin R. Putland,

Bowel cancer is also highly preventable, but men (especially) are slow to do anything about it. Most bowel cancers (some authorities say ALL bowel cancers) begin as POLYPS, which are easily removed during a colonoscopy if they are found soon enough - @grputland

Report abuse

Follow us

Featured Events

View more


View more